You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ZEBETA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ZEBETA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01741623 ↗ Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition Completed IPCA Laboratories Ltd. Phase 1 2012-08-01 This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fasting condition in normal, healthy, adult human subjects.
NCT01744873 ↗ Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition Completed IPCA Laboratories Ltd. Phase 1 2012-08-01 This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult human subjects.
NCT01955759 ↗ Atrial Fibrillation and By-pass Surgery Unknown status Heart Center BH Tuzla Early Phase 1 2013-12-01 The aim of the study is to evaluate whether combined therapy with beta-blocker, amiodarone and statine is better than beta-blocker alone for the prevention of atrial fibrillation after coronary by-pass surgery.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ZEBETA

Condition Name

Condition Name for ZEBETA
Intervention Trials
Fasting 1
Fed 1
Patients With Coronary Artery Disease Scheduled for by Pass Surgery 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ZEBETA
Intervention Trials
Coronary Artery Disease 1
Atrial Fibrillation 1
Malnutrition 1
Myocardial Ischemia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ZEBETA

Trials by Country

Trials by Country for ZEBETA
Location Trials
India 2
Bosnia and Herzegovina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ZEBETA

Clinical Trial Phase

Clinical Trial Phase for ZEBETA
Clinical Trial Phase Trials
Phase 1 2
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ZEBETA
Clinical Trial Phase Trials
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ZEBETA

Sponsor Name

Sponsor Name for ZEBETA
Sponsor Trials
IPCA Laboratories Ltd. 2
Heart Center BH Tuzla 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ZEBETA
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.